New Century AIM VCT Plc UK Regulatory Announcement: Annual Financial Report
LONDON–(BUSINESS WIRE)–
New Century AIM VCT plc
Audited Report and Accounts for the year to 28th February 2021
Company number: 05352611
Financial Summary | 1 |
Chairman’s Statement | 2 |
Details of Directors | 3 |
Management and Administration | 4 |
Directors | 5 |
Strategic Report | 6 |
Investment Portfolio | 8 |
Top Ten Investments | 11 |
Directors’ Report | 12 |
Directors’ Remuneration Report | 16 |
Corporate Governance | 18 |
Independent Auditor’s Report | 22 |
Statement of Comprehensive Income | 29 |
Balance Sheet | 30 |
Statement of Changes in Equity | 31 |
Cash Flow Statement | 32 |
Notes to the Financial Statements | 33 – 44 |
Shareholder Information | 45 |
Financial Summary
| Year ended 28 February 2021 | Year ended 29 February 2020 |
Revenue return per share (pence) for the year | (0.47) | 0.19 |
Total return per share (pence) for the year | 38.49 | 0.66 |
Interim dividend paid per share (pence) | 1.50 | 0.00 |
Proposed final dividend per share (pence) | 6.50 | 0.00 |
Net asset value per share (pence) | 102.96 | 65.97 |
Cumulative value of shareholder investment (net asset value plus cumulative dividends per share) (pence) | 131.78 | 93.29 |
Shareholders’ funds (£’000) | 8,094 | 5,186 |
Chairman’s Statement
It is pleasing to report that following a very difficult period for the Market in March 2020, your fund regained all the declines in its net asset value (NAV) incurred during the early part of the year, and considerably outperformed its benchmark for the twelve months to 28 February 2021.
The NAV of your fund increased by 56.07% to 102.96p (when measured using bid-prices), compared to the FTSE AIM Allshare index which gained 38.13% over the same period. The net asset value plus cumulative dividends rose from 93.29p to 131.78p per share, being an increase of 41.26%.
It is also pleasing to note the further progress since the year end, and that the NAV of 120.02p per share reported for 28 May 2021 (based on mid-prices) is 14.33% higher than that reported, using the same measurement basis, at the 28 February 2021.
We appreciate income is important to our shareholders and the Board is therefore proposing that we pay a final dividend of 6.5p per share in respect of the year ended 28 February 2021. When this is added to the 1.5p interim dividend already paid, this results in a total dividend for the year of 8.0p and represents a yield of 8% based on the fund’s offer price of 100p on 28 May 2021.
The fund has made fifteen further qualifying investments in the period and we are pleased with their progress. We made twelve sales where we either exited or top-sliced a holding.
We are mindful that we could see further volatility this year as the economy has an initial boost from the reopening of lockdown measures, but this could be followed by some businesses starting to experience difficulties in the months ahead as Government support subsides, and the possibility of inflation may also raise its head. That said, the current year has started off positively as commented earlier and we have a wide spread of established companies across a variety of sectors within the fund, and we therefore look forward to the year ahead with optimism.
Finally, the Directors have a duty every five years to ask the shareholders of the Company if they wish the fund to carry on. Therefore, amongst the resolutions shareholders are being asked to vote on at the forthcoming AGM, there is an Ordinary Resolution offering shareholders the opportunity to vote on this particular matter.
Geoffrey Gamble
24 June 2021
Details of Directors
Michael Barnard (Aged 70)
Michael has been employed in stockbroking since 1971. In 1974 he became a Member of the Stock Exchange. During his career his duties have spanned investment advising, investment research, dealing and company management. In 1988 he started his own stockbroking company, MD Barnard & Company Limited which he subsequently sold on 30 November 2017.
Geoffrey Gamble (Aged 62)
Geoffrey started his career with National Westminster Bank plc. He joined Publishing Holdings plc in 1984 and became a director in 1986. He took part in an MBO in 1988, backed by Schroder Ventures (now Permira) to form Charterhouse Communications Group Limited and was instrumental in the satisfactory venture capital exit from that company and its flotation on AIM in 1996. He became managing director of Charterhouse Communications plc in 1999.
Peter William Riley (Aged 76)
Peter qualified as a solicitor in 1969. He retired from practice in 2018.
Ian Cameron-Mowat (Aged 70)
Ian has a BSc 1st degree in electronics and was involved in the early development of computers at Burroughs Machines. He is currently a consultant radiologist to a NHS Trust.
Simon Like (Aged 51)
Simon started his career working for Midland Bank, which later became HSBC plc, and has been employed in stockbroking since 2001. Since then Simon has been managing client money and is one of the senior fund managers at Oberon Investments Limited.
Management and Administration
Registered Office & Registered Number
| 4th Floor, 50 Mark Lane London Company Number: 05352611
|
Company Secretary
|
Tricor Secretaries Limited 4th Floor, 50 Mark Lane London
|
Registrar
|
Neville Registrars Limited Neville House Steelpark Road Halesowen B62 8HD
|
Solicitors
|
Dundas & Wilson 5th Floor, Northwest Wing Bush House Aldwych London
|
Investment Manager and Broker
|
Oberon Investments Limited 1st Floor 12 Hornsby Square Southfields Business Park Basildon Essex
|
Auditor
|
UHY Hacker Young LLP Quadrant House 4 Thomas More Square London
|
Directors
Geoffrey Gamble (Chairman) |
Michael David Barnard |
Peter William Riley |
Ian Cameron-Mowat |
Simon Like |
|
All directors are non-executive. |
|
Audit Committee: |
|
Geoffrey Gamble (Chairman) |
Peter William Riley |
Ian Cameron-Mowat |
Strategic Report
Activities and status
The principal activity of the Company during the year was the making of long-term equity and loan investments in UK Listed, AIM traded and unquoted companies in the United Kingdom. The Company has been listed on the London Stock Exchange since 25 March 2005 and has been granted approval by Her Majesty’s Customs & Revenue as a Venture Capital Trust. The Chairman’s Statement on page 2 and the Investment Manager’s Review below give a review of developments during the year and of future prospects.
The directors consider that the Company was not at any time up to the date of this report a close company within the meaning of Section 414 of the Act.
Investment Manager’s Review
The FTSE AIM All Share index had a good performance throughout the year, although it started negatively with the index falling in early March 2020 as the outbreak of COVID19 started to spread across the world. Since then, however, the trend of the index has been generally up. Many investors started to look at the year as an exceptional year in terms of earnings’ declines, and looked more carefully at the position of companies’ finances and in particular their financial strength to trade successfully once the economy opened up again. We had a couple of false dawns when it was hoped that some sort of return to normality would occur only to be met with a second and third wave of the virus. It is now looking much brighter as the UK is undertaking what looks to be a successful mass vaccination programme which will hopefully allow businesses to open fully and unrestricted from 19 July 2021.
During the year to 28th February 2021 the net asset value (NAV) of your fund increased by 56.07% to 102.96p, compared to the FSTE AIM All Share index which gained 38.13% over the same period. The net asset value of the fund plus cumulative dividends per share increased by 41.26%.
The fund made fifteen qualifying investments in the period, investing in Actual Experience plc, Abingdon Health plc, AFC Energy plc, Deepmatter plc, Destiny Pharma plc, Eden Research plc, ECSC Group plc, Falanx Group plc, Feedback plc, Fusion Antibodies PLC, Gfinity plc, Intelligent Ultrasound Group plc, Mirriad Advertising plc, MyHealthCheck plc and Synairgen plc.
We made twelve sales during the year where we either exited or top-sliced a holding.
The current year has started well, with the NAV of the fund climbing to 120.02p by the end of May 2021 as there has been more optimism by both investors and companies over the prospects for the year ahead. Your fund has a wide spread of investments across a variety of many sectors and we believe that this diversification will help the Company weather any volatility that may occur in the period ahead. These are unprecedented times and with so many countries trying to contain the virus it is impressive how quickly numerous vaccines have been created to help fight the pandemic. We have also begun to see that some companies have recommenced dividend payments again, as they start to become more confident about their future cash flows and prospects. We are also continuing to see many companies using the public markets to raise cash to support their balance sheets and provide growth capital. This in itself can create new opportunities for your fund as it will give us the chance to invest in exciting new prospects.
I am proud about the way the fund has performed this year and I look forward to the year ahead with cautious optimism.
Investment Objective
New Century AIM VCT PLC is a Venture Capital Trust (“VCT”) established under the legislation introduced in the Finance Act 1995. The Company’s principal objectives as set out in the prospectus are to achieve long term capital growth through investment in a diversified portfolio of Qualifying Companies primarily quoted on AIM.
Principal risks and uncertainties
The Company invests its funds primarily in companies traded on AIM, which entail a higher degree of risk than investments in large listed companies. The main risk, therefore, arising from the Company’s activities is market price risk, representing the uncertain realisable values of the Company’s investments. Please refer to the Corporate Governance report on page 18 which provides evidence of the robust review the directors have performed to assess these risks, and also note 22 to these accounts which gives a detailed review of the Company’s risk management.
Environmental matters
Discussion in respect of environmental matters is not considered relevant or material to an understanding of the performance of the Company. The Company does not consider that Greenhouse Gas Emissions disclosure is relevant to the Company on the grounds of immateriality due to its not having its own premises or employees.
Key performance indicators
The financial key performance indicators are set out in the financial summary on page 1.
Viability Statement
In accordance with provision 1 of The UK Corporate Governance Code 2018 the directors have assessed the prospects of the Company over a longer period than the 12 months required by the “Going Concern” provision.
The Board regularly considers the Company’s strategy, including investor demand for the Company’s shares, and a three year period is therefore considered to be an appropriate and reasonable time horizon.
The Board has carried out a robust assessment of the principal risks facing the Company and its current position, including those which may adversely impact its business model, future performance, solvency or liquidity. The principal risks faced by the Company and the procedures in place to monitor and mitigate them are set out in note 22.
The Board has also considered the Company’s cash flow projections and found these to be realistic and reasonable.
Based on the above assessment the Board confirms that it has a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the three year period to 28 February 2024.
Geoffrey Gamble
Chairman
24 June 2021
Investment Portfolio
Security | Original | Valuation at | Cost | Valuation |
| £ | £ | % | % |
|
|
|
|
|
Qualifying Investments | 6,753,744 | 7,794,913 | 91.77 | 95.91 |
Non-qualifying Investments | 482,628 | 209,312 | 6.56 | 2.58 |
| 7,236,372 | 8,004,225 | 98.33 | 98.49 |
Uninvested funds | 123,089 | 123,089 | 1.67 | 1.51 |
| 7,359,461 | 8,127,314 | 100.00 | 100.00 |
Qualifying Investments |
|
|
|
|
AIM quoted |
|
|
|
|
Abingdon Health plc | 35,218 | 32,777 | 0.48 | 0.40 |
Access Intelligence plc | 10,053 | 29,000 | 0.14 | 0.36 |
Actual Experience plc | 63,174 | 70,638 | 0.86 | 0.87 |
AFC Energy | 50,254 | 168,125 | 0.68 | 2.07 |
Angle plc | 125,880 | 157,237 | 1.71 | 1.93 |
Anglo African Oil & Gas plc | 45,229 | 675 | 0.61 | 0.01 |
Audioboom Group plc | 178,406 | 308,880 | 2.42 | 3.80 |
Bango plc | 7,563 | 36,225 | 0.10 | 0.45 |
Belvoir Lettings plc | 23,320 | 32,800 | 0.32 | 0.40 |
Bigblu Broadband plc | 239,452 | 391,788 | 3.25 | 4.82 |
Bilby plc | 156,673 | 91,381 | 2.13 | 1.12 |
Blackbird plc | 97,991 | 461,175 | 1.33 | 5.67 |
Bould Opportunities plc | 35,179 | 0 | 0.48 | 0.00 |
Brighton Pier Group plc | 50,253 | 11,031 | 0.68 | 0.14 |
C4X Discovery Holding plc | 65,329 | 157,733 | 0.89 | 1.94 |
Cloudbuy plc | 58,483 | 228 | 0.79 | 0.00 |
Cloudcall Group plc | 20,230 | 30,100 | 0.27 | 0.37 |
Coral Products plc | 118,095 | 83,333 | 1.60 | 1.03 |
Creo Medical Group plc | 30,053 | 86,159 | 0.41 | 1.06 |
Cyanconnode Holdings plc | 376,755 | 46,726 | 5.12 | 0.57 |
DCD Media plc | 562,800 | 1,700 | 7.65 | 0.02 |
Deepmatter Group plc | 49,754 | 81,840 | 0.68 | 1.01 |
Deepverge plc | 121,304 | 93,840 | 1.65 | 1.15 |
Destiny Pharma plc | 50,254 | 86,923 | 0.68 | 1.07 |
Diaceutics plc | 10,314 | 17,415 | 0.14 | 0.21 |
DP Poland plc | 20,113 | 11,939 | 0.27 | 0.15 |
Ecsc Group plc | 20,104 | 23,637 | 0.27 | 0.29 |
Eden Research plc | 30,152 | 97,000 | 0.41 | 1.19 |
Escape Hunt plc | 31,006 | 5,530 | 0.42 | 0.07 |
Falanx Group Ltd | 150,964 | 97,653 | 2.05 | 1.20 |
Faron Pharmaceuticals Ltd | 25,128 | 32,650 | 0.34 | 0.40 |
Feedback plc | 100,508 | 117,629 | 1.37 | 1.45 |
Fusion Antibodies plc | 12,064 | 15,534 | 0.16 | 0.19 |
Gear4Music Holdings plc | 27,121 | 150,070 | 0.37 | 1.85 |
Gfinity plc | 116,218 | 153,829 | 1.58 | 1.89 |
Hunters Property plc | 251,256 | 325,000 | 3.41 | 4.00 |
IDE Group Holdings plc | 52,763 | 1,396 | 0.72 | 0.02 |
|
|
|
|
|
|
|
|
|
|
Security | Original | Valuation at | Cost | Valuation |
| £ | £ | % | % |
|
|
|
|
|
Ideagen plc | 28,430 | 227,117 | 0.39 | 2.79 |
Immotion Group plc | 130,661 | 74,678 | 1.78 | 0.92 |
I-Nexus Global plc | 70,353 | 5,494 | 0.96 | 0.07 |
Inspired Energy plc | 51,370 | 259,133 | 0.70 | 3.19 |
Intelligent Ultrasound Group plc | 170,848 | 149,908 | 2.32 | 1.84 |
K3 Business Technology Group plc | 90,360 | 178,821 | 1.23 | 2.20 |
Keywords Studios plc | 5,563 | 113,040 | 0.08 | 1.39 |
Lightwaverf plc | 45,233 | 3,177 | 0.61 | 0.04 |
Location Sciences Group plc | 132,946 | 29,161 | 1.81 | 0.36 |
M.Winkworth plc | 64,320 | 108,800 | 0.87 | 1.34 |
Marechale Capital plc | 133,828 | 65,323 | 1.82 | 0.80 |
Maxcyte Inc | 25,128 | 348,212 | 0.34 | 4.28 |
Microsaic Systems plc | 164,417 | 7,792 | 2.23 | 0.10 |
Mirriad Advertising plc | 30,154 | 38,850 | 0.41 | 0.48 |
Myhealthchecked plc | 200,550 | 366,282 | 2.73 | 4.51 |
N4 Pharma plc | 60,304 | 54,600 | 0.82 | 0.67 |
Open Orphan plc | 115,581 | 137,470 | 1.57 | 1.69 |
Pelatro plc | 25,128 | 14,400 | 0.34 | 0.18 |
PHSC plc | 182,910 | 45,500 | 2.49 | 0.56 |
Polarean Imaaging plc | 30,154 | 129,600 | 0.41 | 1.59 |
Property Franchise Group plc | 100,503 | 190,000 | 1.37 | 2.34 |
Quixant plc | 6,935 | 17,700 | 0.09 | 0.22 |
Rosslyn Data plc | 27,037 | 5,339 | 0.37 | 0.07 |
Scancell Holdings plc | 130,618 | 217,361 | 1.77 | 2.67 |
Scholium Group plc | 50,253 | 15,500 | 0.68 | 0.19 |
SEEEN plc | 150,754 | 130,000 | 2.05 | 1.60 |
Solid State plc | 40,134 | 125,070 | 0.55 | 1.54 |
SRT Marine Systems plc | 27,139 | 52,500 | 0.37 | 0.65 |
Sysgroup plc | 99,178 | 65,780 | 1.35 | 0.81 |
Tekcapital plc | 77,499 | 52,200 | 1.05 | 0.64 |
Touchstar plc | 281,400 | 88,750 | 3.82 | 1.09 |
TP Group plc | 109,278 | 45,157 | 1.49 | 0.56 |
Tristel plc | 38,409 | 578,592 | 0.52 | 7.12 |
ULS Technology plc | 48,241 | 101,160 | 0.66 | 1.24 |
Verici Dx plc | 35,178 | 119,875 | 0.48 | 1.47 |
Vianet Group plc | 40,175 | 24,050 | 0.55 | 0.30 |
Total AIM quoted qualifying investments | 6,537,622 | 7,794,913 | 88.83 | 95.91
|
Unlisted qualifying Investments |
|
|
|
|
Invocas Group plc | 100,400 | 0 | 1.36 | 0.00 |
Optare plc | 45,027 | 0 | 0.61 | 0.00 |
Outsourcery plc | 50,752 | 0 | 0.70 | 0.00 |
Syqic plc | 19,943 | 0 | 0.27 | 0.00 |
Total Unlisted qualifying investments | 216,122 | 0 | 2.94 | 0.00 |
|
|
|
|
|
Total Qualifying Investments | 6,753,744 | 7,794,913 | 91.77 | 95.91 |
|
|
|
|
|
Security | Original | Valuation at | Cost | Valuation |
| £ | £ | % | % |
Non-qualifying Investments |
|
|
|
|
AIM quoted |
|
|
|
|
Audioboom Group plc | 1,163 | 429 | 0.02 | 0.01 |
Bango plc | 291 | 414 | 0.00 | 0.01 |
Cyanconnode Holdings plc | 131 | 8 | 0.00 | 0.00 |
Driver Group plc | 8,992 | 5,000 | 0.12 | 0.06 |
Gateley Holdings plc | 14,627 | 26,400 | 0.20 | 0.31 |
IDE Group Holdings plc | 218 | 2 | 0.00 | 0.00 |
K3 Business Technology Grp plc | 131 | 179 | 0.00 | 0.00 |
Rotala plc | 60,795 | 51,644 | 0.83 | 0.64 |
Tristel plc | 60 | 588 | 0.00 | 0.01 |
|
|
|
|
|
| 86,408 | 84,664 | 1.17 | 1.04 |
UK Listed |
|
|
|
|
Aviva plc | 22,268 | 18,090 | 0.30 | 0.22 |
Centrica plc | 10,074 | 1,582 | 0.14 | 0.02 |
Imperial Brands plc | 23,764 | 13,325 | 0.32 | 0.16 |
Investec plc | 202,821 | 70,975 | 2.77 | 0.88 |
Twentyfour Income Fund Ltd | 9,852 | 9,360 | 0.13 | 0.12 |
Vodafone Group plc | 20,590 | 11,316 | 0.28 | 0.14 |
|
|
|
|
|
| 289,369 | 124,648 | 3.93 | 1.54 |
Unlisted Investments |
|
|
|
|
China Food Company plc | 65,969 | 0 | 0.91 | 0.00 |
Gable Holdings Inc | 12,112 | 0 | 0.16 | 0.00 |
Mar City plc | 10,053 | 0 | 0.14 | 0.00 |
Sorbic International plc | 18,717 | 0 | 0.25 | 0.00 |
|
|
|
|
|
| 106,851 | 0 | 1.46 | 0.00 |
|
|
|
|
|
Total non-qualifying investments | 482,628 | 209,312 | 6.56 | 2.58 |
|
|
|
|
|
Security | Original | Valuation at | Cost | Valuation |
| £ | £ | % | % |
|
|
|
|
|
Tristel plc | 38,469 | 579,180 | 0.52% | 7.13% |
Blackbird plc | 97,991 | 461,175 | 1.33% | 5.67% |
Bigblu Broadband plc | 239,452 | 391,788 | 3.25% | 4.82% |
Myhealthchecked plc | 200,550 | 366,282 | 2.73% | 4.51% |
Maxcyte Inc Com | 25,128 | 348,212 | 0.34% | 4.28% |
Hunters Property plc | 251,256 | 325,000 | 3.41% | 4.00% |
Audioboom Group plc | 179,569 | 309,309 | 2.44% | 3.81% |
Inspired Energy plc | 51,370 | 259,133 | 0.70% | 3.19% |
Ideagen plc | 28,430 | 227,117 | 0.39% | 2.79% |
Scancell Holdings plc | 130,618 | 217,361 | 1.77% | 2.67% |
The investments tabulated above are expressed as a percentage of the Company’s investment portfolio including uninvested cash.
Directors’ Report
The directors present their report and the audited financial statements for the year to 28 February 2021.
Corporate Governance
The Corporate Governance report on pages 18 to 21 forms part of the directors’ report.
Results and dividends paid
| Year to 28 February 2021 | Year to | ||
| Revenue | Capital | Revenue | Capital |
| £’000 | £’000 | £’000 | £’000 |
Return on ordinary activities after taxation | (36) | 3,063 | 15 | 38 |
|
|
|
|
|
Appropriated as follows: |
|
|
|
|
|
|
|
|
|
Interim dividend paid in respect of current period |
|
|
|
|
Revenue – Nil (Nil) per share | – | – | – | – |
|
|
|
|
|
Capital – 1.50p (Nil) per share | – | (118) | – | – |
|
|
|
|
|
Final dividend paid in respect of prior period |
|
|
|
|
Revenue – Nil (0.186p) per share | – | – | (15) | – |
|
|
|
|
|
Capital – Nil (3.314p) per share | – | – | – | (260) |
|
|
|
|
|
|
|
|
|
|
Transfers to reserves | (36) | 2,945 | – | (222) |
The directors propose to declare a final dividend for the year ended 28 February 2021 of 6.5p per share which, when added to the interim dividend of 1.5p per share (already paid on 4 December 2020), gives a total dividend for the year of 8.0p per share.
There was no dividend declared for the year ended 29 February 2020.
Directors
The directors of the Company are required to notify their interests under Disclosure and Transparency Rule 3.12R. The membership of the Board and their beneficial interests in the ordinary shares of the Company are set out below:
| Year ended 28 February 2021 | Year ended 29 February 2020
|
Michael Barnard Geoffrey Gamble Peter William Riley Ian Cameron-Mowat |
2,159,035 97,125 59,185 110,904 |
2,159,035 61,732 59,185 110,904 |
Simon Like | 8,800 | 8,800 |
|
|
|
All of the directors’ share interests shown above are held beneficially. There have been no changes in the directors’ share interests between 28 February 2021 and the date of this report.
Brief biographical notes on the directors are given on page 3. The director, retiring in accordance with the Company’s Articles of Association, is Geoffrey Gamble, who being eligible will offer himself for re-election at the forthcoming Annual General Meeting (AGM). The directors believe his experience in small companies is a great benefit to the Board and recommend his re-election.
None of the directors has a contract of service with the Company and, except as mentioned below under the heading “Management”, there were no contracts that subsisted during the year in which a director was materially interested and which was significant in relation to the Company’s business.
Management
MD Barnard & Co. Ltd (now called Oberon Investments Limited) has acted as investment manager to the Company since inception. The principal terms of the Investment Management Agreement are set out in Note 6 to the Financial Statements.
Substantial shareholdings
As at 28 February 2021 the Company had been notified of the following shareholdings representing 3 per cent or more of the Company’s issued share capital during the year under review or at the date of this report:
| Number | Percentage of share capital |
Michael Barnard Geoffrey Williams Nigel Shanks David Trotman John Brice Roger Carey |
2,159,035 391,570 364,820 324,000 290,988 241,048 |
27.47% 4.98% 4.64% 4.12% 3.70% 3.07%
|
Acquisition of own shares
During the year the Company did not re-purchase any of its own shares.
Structure, rights and restrictions concerning the Company’s share capital
Throughout the Company’s financial year there were 7,860,937 ordinary shares in issue. No shares were issued or bought back during the year. The rights and obligations attached to the Company’s ordinary shares are set out in the Company’s Articles of Association, copies of which can be obtained from Companies House. The Company has only one class of ordinary share and each share has attached to it full voting rights, dividends and capital distribution rights (including on a winding up) and do not confer any rights of redemption.
Ordinary shareholders also have the right to receive copies of the Company’s report and accounts, to attend and speak at general meetings and to appoint proxies.
There is one shareholder, Michael Barnard, who is a major shareholder in the Company with a 27.47% shareholding. He is also a director of the Company and taken together he is considered to have a significant influence over the Company. Other than Michael Barnard, there are no other shareholders who have a significant direct or indirect shareholding in the Company.
In accordance with Schedule 7 of the Large and Medium Size Companies and Groups (Accounts and Reports) Regulations 2008, as amended, the directors disclose the following information:
- The Company’s capital structure and voting rights are summarised above, and there are no restrictions on voting rights nor any agreement between holders of securities that result in restrictions on the transfer of securities or on voting rights;
- There exist no securities carrying special rights with regard to the control of the Company;
- The rules concerning the appointment and replacement of directors, amendment of the Articles of Association and powers to issue or buy back of the Company’s shares are contained in the Articles of Association of the Company and the Companies Act 2006;
- The Company does not have an employee share scheme;
- There are no agreements to which the Company is party that may affect its control following a takeover bid; and
- There are no agreements between the Company and its directors providing for compensation for loss of office that may occur following a takeover bid or for any other reason.
Appointment of Directors
The directors are subject to re-election by rotation, with one of the directors being re-elected annually at the AGM.
Creditor payment policy
The Company’s payment policy is to agree terms of payment before business is transacted and to settle accounts in accordance with those terms. The Company’s principal expenses such as investment management fees and administration fees are paid quarterly in arrears in accordance with the respective agreements. Accordingly the Company had no material trade creditors at the year end.
Streamlined Energy and Carbon Reporting
There are new reporting requirements which make it mandatory for companies to report the amount of energy they use during their financial year. The Company’s energy usage is below the de minimis level of 40,000kWh.
Post balance sheet events
Details of the post balance sheet event are set out in note 27.
Contacts
NEW CENTURY AIM VCT PLC